A61K 31/575
Substituted in position 17 beta by a chain of three or more
Official title: substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
A61K31/575 (Substituted in position 17 beta by a chain of three or more) appears on 1,389 US grants and 2,421 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,389
- Published applications
- 2,421
- Assignees
- 1,117
- Inventors
- 4,184
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 14 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 13 | 0 |
| 1994 | 15 | 0 |
| 1995 | 16 | 0 |
| 1996 | 28 | 0 |
| 1997 | 19 | 0 |
| 1998 | 30 | 0 |
| 1999 | 26 | 0 |
| 2000 | 28 | 0 |
| 2001 | 23 | 10 |
| 2002 | 30 | 30 |
| 2003 | 19 | 39 |
| 2004 | 13 | 52 |
| 2005 | 10 | 32 |
| 2006 | 8 | 50 |
| 2007 | 6 | 35 |
| 2008 | 4 | 42 |
| 2009 | 10 | 61 |
| 2010 | 14 | 67 |
| 2011 | 22 | 69 |
| 2012 | 39 | 86 |
| 2013 | 34 | 86 |
| 2014 | 50 | 117 |
| 2015 | 65 | 125 |
| 2016 | 76 | 124 |
| 2017 | 75 | 143 |
| 2018 | 72 | 132 |
| 2019 | 96 | 163 |
| 2020 | 90 | 184 |
| 2021 | 89 | 144 |
| 2022 | 86 | 159 |
| 2023 | 57 | 143 |
| 2024 | 65 | 118 |
| 2025 | 69 | 120 |
| 2026 | 35 | 90 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of activating cells via PTP 1B inhibition29 Sep 2026US 12,746,285 B2Monash University
- Herbal bioactives based immunostimulant formulation for poultry birds and cattle and preparation thereof15 Sep 2026US 12,734,134 B2Edhas Technologies Inc.
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency28 Jul 2026US 12,691,127 B2Corcept Therapeutics, Inc.
- Sleep formulation1 Oct 2026US 2026/0294816 A1NightWise, LLC
- Lipid nanoparticle compositions and uses thereof1 Oct 2026US 2026/0294935 A1Beijing Jitai Life Science Ltd
- Pharmaceuticl compositions comprising bile acid compounds for oral delivery of therapeutic peptides1 Oct 2026US 2026/0294936 A1Waterstone Pharmaceuticals(Wuhan) Co., Ltd.
- Pharmaceutical formulation comprising lanosterol, derivative thereof, and cyclodextrin1 Oct 2026US 2026/0295073 A1Carboexpert Inc.
- Compositions and methods of controlling mammalian satiety24 Sep 2026US 2026/0284002 A1VitaKey Inc.
Most cited
By later US patents
- Method and apparatus for removing arterial constriction264US 4,636,195 A1987
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Pharmaceutical composition containing acid addition salt of basic drug163US 6,255,502 B1Farmarc Nederland BV · 2001
- Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover)144US 6,153,607 AUniversity of Miami · 2000